Erik L. Ridley and Philip Ward[email protected]AIRadNet broadens AI focus with acquisitions of Aidence, QuantibImaging services provider RadNet has acquired Dutch artificial intelligence (AI) software developers Aidence and Quantib in deals that the company hopes will enable wide-scale screening programs for lung and prostate cancer.January 23, 2022Page 1 of 1Top StoriesAIU.S. FDA may need to clarify SaMD validation standardsIn a video interview, a Dana-Farber Cancer Institute expert describes what the "rigor spectrum" is in validation study designs.Molecular ImagingPSMA-PET/CT may replace NaF-PET/CT in advanced prostate cancerWomens ImagingPreop breast MRI improves surgical planning, but use disparities remainWomens ImagingFIGO classification from MRI leads to moderate agreement among radsSponsor ContentRegister Now: Breaking Barriers in Breast Imaging Webinar